Logo-bi
Bioimpacts. 2013;3(1): 1-4. doi: 10.5681/bi.2013.009
PMID: 23678463        PMCID: PMC3648910

Editorial

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy

S. Moein Moghimi * , Fatemeh Rahbarizadeh, Davoud Ahmadvand, Ladan Parhamifar

Cited by CrossRef: 0




As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons